Genome-wide disruption of 5-hydroxymethylcytosine in a mouse model of autism

Human Molecular Genetics

Volumn 24, Issue 24, 2015, Pages 7121-7131

  Papale, Ligia A ^a   Zhang, Qi ^b   Li, Sisi ^a,c   Chen, Kailei ^b   Keleş, Sündüz ^b   Alisch, Reid S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; TRANSCRIPTION FACTOR; 5-HYDROXYMETHYLCYTOSINE; CNTNAP2 PROTEIN, MOUSE; CYTOSINE; DNA; MEMBRANE PROTEIN; NERVE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; CHEMICAL LABELING; CONTROLLED STUDY; CORPUS STRIATUM; GENE DISRUPTION; GENETIC ASSOCIATION; HIGH THROUGHPUT SEQUENCING; MALE; MORPHOGENESIS; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PURIFICATION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DISEASE MODEL; DNA METHYLATION; GENETIC EPIGENESIS; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOLECULAR GENETICS;

ANIMALS; AUTISTIC DISORDER; CORPUS STRIATUM; CYTOSINE; DISEASE MODELS, ANIMAL; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE ANNOTATION; NERVE TISSUE PROTEINS;

EID: 84949027303     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv411     Document Type: Article

References (73)

1. Association, Psychiatric Association. (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Association, Psychiatric Association, Washington, DC.
2. Geschwind, D.H. (2009) Advances in autism. Annu. Rev. Med., 60, 367-380.
3. Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J. et al. (2007) Strong association of de novo copy number mutations with autism. Science, 316, 445-449.
4. Glessner, J.T., Wang, K., Cai, G., Korvatska, O., Kim, C.E., Wood, S., Zhang, H., Estes, A., Brune, C.W., Bradfield, J.P. et al. (2009) Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature, 459, 569-573.
5. Weiss, L.A., Arking, D.E., Daly, M.J. and Chakravarti, A. (2009) A genome-wide linkage and association scan reveals novel loci for autism. Nature, 461, 802-808.
6. Tordjman, S., Somogyi, E., Coulon, N., Kermarrec, S., Cohen, D., Bronsard, G., Bonnot, O., Weismann-Arcache, C., Botbol, M., Lauth, B. et al. (2014) Gene x environment interactions in autism spectrum disorders: role of epigenetic mechanisms. Front. Psychiatry, 5, 53.
7. Li, E., Bestor, T.H. and Jaenisch, R. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell, 69, 915-926.
8. Li, E., Beard, C. and Jaenisch, R. (1993) Role for DNA methylation in genomic imprinting. Nature, 366, 362-365.
9. Reik, W. (2007) Stability and flexibility of epigenetic gene regulation in mammalian development. Nature, 447, 425-432.
10. Zemach, A., McDaniel, I.E., Silva, P. and Zilberman, D. (2010) Genome-wide evolutionary analysis of eukaryotic DNA methylation. Science, 328, 916-919.
11. Grayson, D.R., Jia, X., Chen, Y., Sharma, R.P., Mitchell, C.P., Guidotti, A. and Costa, E. (2005) Reelin promoter hypermethylation in schizophrenia. Proc. Natl Acad. Sci. USA, 102, 9341- 9346.
12. Abdolmaleky, H.M., Cheng, K.H., Faraone, S.V., Wilcox, M., Glatt, S.J., Gao, F., Smith, C.L., Shafa, R., Aeali, B., Carnevale, J. et al. (2006) Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet., 15, 3132-3145.
13. Kuratomi, G., Iwamoto, K., Bundo, M., Kusumi, I., Kato, N., Iwata, N., Ozaki, N. and Kato, T. (2008) Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Mol. Psychiatry, 13, 429-441.
14. Poulter, M.O., Du, L., Weaver, I.C., Palkovits, M., Faludi, G., Merali, Z., Szyf, M. and Anisman, H. (2008) GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol. Psychiatry, 64, 645-652.
15. Yao, B. and Jin, P. (2014) Cytosine modifications in neurodevelopment and diseases. Cell. Mol. Life Sci., 71, 405-418.
16. Szulwach, K.E., Li, X., Li, Y., Song, C.X., Wu, H., Dai, Q., Irier, H., Upadhyay, A.K., Gearing, M., Levey, A.I. et al. (2011) 5-hmCmediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat. Neurosci., 14, 1607-1616.
17. Szulwach, K.E., Li, X., Li, Y., Song, C.X., Han, J.W., Kim, S., Namburi, S., Hermetz, K., Kim, J.J., Rudd, M.K. et al. (2011) Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet., 7, e1002154.
18. Kriaucionis, S. and Heintz, N. (2009) The nuclear DNA base 5- hydroxymethylcytosine is present in Purkinje neurons and the brain. Science, 324, 929-930.
19. Munzel, M., Globisch, D., Bruckl, T., Wagner, M., Welzmiller, V., Michalakis, S., Muller, M., Biel, M. and Carell, T. (2010) Quantification of the sixth DNA base hydroxymethylcytosine in the brain. Angew Chem. Int. Ed. Engl., 49, 5375-5377.
20. Song, C.X., Szulwach, K.E., Fu, Y., Dai, Q., Yi, C., Li, X., Li, Y., Chen, C.H., Zhang, W., Jian, X. et al. (2011) Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotech., 29, 68-72.
21. Khare, T., Pai, S., Koncevicius, K., Pal, M., Kriukiene, E., Liutkeviciute, Z., Irimia, M., Jia, P., Ptak, C., Xia, M. et al. (2012) 5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary. Nat. Struct. Mol. Biol., 19, 1037-1043.
22. Al-Mahdawi, S., Virmouni, S.A. and Pook, M.A. (2014) The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases. Front. Neurosci., 8, 397.
23. Mellen, M., Ayata, P., Dewell, S., Kriaucionis, S. and Heintz, N. (2012) MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell, 151, 1417-1430.
24. Zhubi, A., Chen, Y., Dong, E., Cook, E.H., Guidotti, A. and Grayson, D.R. (2014) Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum. Transl. Psychiatry, 4, e349.
25. Villar-Menendez, I., Blanch, M., Tyebji, S., Pereira-Veiga, T., Albasanz, J.L., Martin, M., Ferrer, I., Perez-Navarro, E. and Barrachina, M. (2013) Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease. Neuromolecular Med., 15, 295-309.
26. Wang, F., Yang, Y., Lin, X., Wang, J.Q., Wu, Y.S., Xie, W., Wang, D., Zhu, S., Liao, Y.Q., Sun, Q. et al. (2013) Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease. Hum. Mol. Genet., 22, 3641-3653.
27. Chouliaras, L., Mastroeni, D., Delvaux, E., Grover, A., Kenis, G., Hof, P.R., Steinbusch, H.W., Coleman, P.D., Rutten, B.P. and van den Hove, D.L. (2013) Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol. Aging., 34, 2091-2099.
28. Strauss, K.A., Puffenberger, E.G., Huentelman, M.J., Gottlieb, S., Dobrin, S.E., Parod, J.M., Stephan, D.A. and Morton, D.H. (2006) Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N. Engl. J. Med., 354, 1370-1377.
29. Alarcon, M., Abrahams, B.S., Stone, J.L., Duvall, J.A., Perederiy, J.V., Bomar, J.M., Sebat, J., Wigler, M., Martin, C.L., Ledbetter, D.H. et al. (2008) Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am. J. Hum. Genet., 82, 150-159.
30. Arking, D.E., Cutler, D.J., Brune, C.W., Teslovich, T.M., West, K., Ikeda, M., Rea, A., Guy, M., Lin, S., Cook, E.H. et al. (2008)A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am. J. Hum. Genet., 82, 160-164.
31. Bakkaloglu, B., O'Roak, B.J., Louvi, A., Gupta, A.R., Abelson, J.F., Morgan, T.M., Chawarska, K., Klin, A., Ercan-Sencicek, A.G., Stillman, A.A. et al. (2008) Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am. J. Hum. Genet., 82, 165-173.
32. Vernes, S.C., Newbury, D.F., Abrahams, B.S., Winchester, L., Nicod, J., Groszer, M., Alarcon, M., Oliver, P.L., Davies, K.E., Geschwind, D.H. et al. (2008) A functional genetic link between distinct developmental language disorders. N. Engl. J. Med., 359, 2337-2345.
33. Scott-Van Zeeland, A.A., Abrahams, B.S., Alvarez-Retuerto, A.I., Sonnenblick, L.I., Rudie, J.D., Ghahremani, D., Mumford, J.A., Poldrack, R.A., Dapretto, M., Geschwind, D.H. et al. (2010) Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci. Transl. Med., 2, 56ra80.
34. Poliak, S., Gollan, L., Martinez, R., Custer, A., Einheber, S., Salzer, J.L., Trimmer, J.S., Shrager, P. and Peles, E. (1999) Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron, 24, 1037-1047.
35. Poliak, S., Salomon, D., Elhanany, H., Sabanay, H., Kiernan, B., Pevny, L., Stewart, C.L., Xu, X., Chiu, S.Y., Shrager, P. et al. (2003) Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J. Cell Biol., 162, 1149-1160.
36. Penagarikano, O., Abrahams, B.S., Herman, E.I., Winden, K.D., Gdalyahu, A., Dong, H., Sonnenblick, L.I., Gruver, R., Almajano, J., Bragin, A. et al. (2011) Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autismrelated deficits. Cell, 147, 235-246.
37. Coufal, N.G., Garcia-Perez, J.L., Peng, G.E., Yeo, G.W., Mu, Y., Lovci, M.T., Morell, M., O'Shea, K.S., Moran, J.V. and Gage, F.H. (2009) L1 retrotransposition in human neural progenitor cells. Nature, 460, 1127-1131.
38. Secco, D., Wang, C., Shou, H., Schultz, M.D., Chiarenza, S., Nussaume, L., Ecker, J.R., Whelan, J. and Lister, R. (2015) Stress induced gene expression drives transient DNA methylation changes at adjacent repetitive elements. eLife., 4, 1-26.
39. Persico, A.M., D'Agruma, L., Maiorano, N., Totaro, A., Militerni, R., Bravaccio, C., Wassink, T.H., Schneider, C., Melmed, R., Trillo, S. et al. (2001) Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol. Psychiatry, 6, 150-159.
40. Kim, H.G., Kishikawa, S., Higgins, A.W., Seong, I.S., Donovan, D.J., Shen, Y., Lally, E., Weiss, L.A., Najm, J., Kutsche, K. et al. (2008) Disruption of neurexin 1 associated with autism spectrum disorder. Am. J. Hum. Genet., 82, 199-207.
41. Bienvenu, T. and Chelly, J. (2006) Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat. Rev. Genet., 7, 415-426.
42. Gharani, N., Benayed, R., Mancuso, V., Brzustowicz, L.M. and Millonig, J.H. (2004) Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder. Mol. Psychiatry, 9, 474-484.
43. Won, H., Mah, W. and Kim, E. (2013) Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses. Front. Mol. Neurosci., 6, 19.
44. Kerin, T., Ramanathan, A., Rivas, K., Grepo, N., Coetzee, G.A. and Campbell, D.B. (2012) A noncoding RNA antisense to moesin at 5p14.1 in autism. Sci. Transl. Med., 4, 128ra140.
45. Qureshi, I.A. and Mehler, M.F. (2012) Emerging roles of noncoding RNAs in brain evolution, development, plasticity and disease. Nat. Rev. Neurosci., 13, 528-541.
46. Ohadi, M., Mirabzadeh, A., Esmaeilzadeh-Gharehdaghi, E., Rezazadeh, M., Hosseinkhanni, S., Oladnabi, M., Firouzabadi, S.G. and Darvish, H. (2012) Novel evidence of the involvement of calreticulin in major psychiatric disorders. Prog. Neuro-psychopharmacol. Biol. Psychiatry, 37, 276-281.
47. Scobie, K.N., Hall, B.J., Wilke, S.A., Klemenhagen, K.C., Fujii- Kuriyama, Y., Ghosh, A., Hen, R. and Sahay, A. (2009) Kruppel-like factor 9 is necessary for late-phase neuronal maturation in the developing dentate gyrus and during adult hippocampal neurogenesis. J. Neurosci., 29, 9875-9887.
48. Duncan, J., Johnson, S. and Ou, X.M. (2012) Monoamine oxidases in major depressive disorder and alcoholism. Drug Discov. Ther., 6, 112-122.
49. Mahishi, L. and Usdin, K. (2006) NF-Y, AP2, Nrf1 and Sp1 regulate the fragile X-related gene 2 (FXR2). Biochem. J., 400, 327- 335.
50. Chiocchetti, A.G., Kopp, M., Waltes, R., Haslinger, D., Duketis, E., Jarczok, T.A., Poustka, F., Voran, A., Graab, U., Meyer, J. et al. (2015) Variants of the CNTNAP2 5' promoter as risk factors for autism spectrum disorders: a genetic and functional approach. Mol. Psychiatry, 20, 839-849.
51. Woo, T.U., Walsh, J.P. and Benes, F.M. (2004) Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry, 61, 649-657.
52. Jamain, S., Quach, H., Betancur, C., Rastam, M., Colineaux, C., Gillberg, I.C., Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C. et al. (2003) Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet., 34, 27-29.
53. Szatmari, P., Paterson, A.D., Zwaigenbaum, L., Roberts, W., Brian, J., Liu, X.Q., Vincent, J.B., Skaug, J.L., Thompson, A.P., Senman, L. et al. (2007) Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet., 39, 319-328.
54. Durand, C.M., Betancur, C., Boeckers, T.M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsater, H. et al. (2007) Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet., 39, 25-27.
55. Berkel, S., Marshall, C.R., Weiss, B., Howe, J., Roeth, R., Moog, U., Endris, V., Roberts, W., Szatmari, P., Pinto, D. et al. (2010) Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder andmental retardation. Nat. Genet., 42, 489-491.
56. Sato, D., Lionel, A.C., Leblond, C.S., Prasad, A., Pinto, D., Walker, S., O'Connor, I., Russell, C., Drmic, I.E., Hamdan, F.F. et al. (2012) SHANK1 deletions in males with autism spectrum disorder. Am. J. Hum. Gen., 90, 879-887.
57. Jamain, S., Betancur, C., Quach, H., Philippe, A., Fellous, M., Giros, B., Gillberg, C., Leboyer, M. and Bourgeron, T. (2002) Linkage and association of the glutamate receptor 6 gene with autism. Mol. Psychiatry, 7, 302-310.
58. O'Roak, B.J., Vives, L., Fu, W., Egertson, J.D., Stanaway, I.B., Phelps, I.G., Carvill, G., Kumar, A., Lee, C., Ankenman, K. et al. (2012) Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science, 338, 1619-1622.
59. O'Roak, B.J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B.P., Levy, R., Ko, A., Lee, C., Smith, J.D. et al. (2012)Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature, 485, 246-250.
60. Langmead, B., Trapnell, C., Pop, M. and Salzberg, S.L. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol., 10, R25.
61. Kharchenko, P.V., Tolstorukov, M.Y. and Park, P.J. (2008) Design and analysis of ChIP-seq experiments for DNA-binding proteins. Nat. Biotech., 26, 1351-1359.
62. Kuan, P.F., Chung, D., Pan, G., Thomson, J.A., Stewart, R. and Keles, S. (2009) A statistical framework for the analysis of ChIP-Seq data. J. Am. Stat. Assoc., 106, 891-903.
63. Welch, R. and Keles, S. (2015), R package, in press.
64. Robinson, M.D., McCarthy, D.J. and Smyth, G.K. (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics, 26, 139-140.
65. Carlson, M. (2015) Bioconductor, R. (ed.), in press.
66. Bailey, J.A., Yavor, A.M., Massa, H.F., Trask, B.J. and Eichler, E.E. (2001) Segmental duplications: organization and impact within the current human genome project assembly. Genome Res., 11, 1005-1017.
67. Shen, L., Shao, N.Y., Liu, X., Maze, I., Feng, J. and Nestler, E.J. (2013) diffReps: detecting differential chromatin modification sites from ChIP-seq data with biological replicates. PLoS One., 8, e65598.
68. Yu, G., Wang, L.G., Han, Y. and He, Q.Y. (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. Omics., 16, 284-287.
69. Geifman, N., Monsonego, A. and Rubin, E. (2010) The Neural/ Immune Gene Ontology: clipping the Gene Ontology for neurological and immunological systems. BMC Bioinformatics, 11, 458.
70. Mathelier, A., Zhao, X., Zhang, A.W., Parcy, F., Worsley-Hunt, R., Arenillas, D.J., Buchman, S., Chen, C.Y., Chou, A., Ienasescu, H. et al. (2014) JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucl. Acids Res., 42, D142-D147.
71. Grant, C.E., Bailey, T.L. and Noble, W.S. (2011) FIMO: scanning for occurrences of a given motif. Bioinformatics, 27, 1017-1018.
72. Bailey, T.L., Johnson, J., Grant, C.E. and Noble, W.S. (2015) The MEME Suite. Nucl. Acids Res., 43, W39-W49.
73. Gupta, S., Stamatoyannopoulos, J.A., Bailey, T.L. and Noble, W.S. (2007) Quantifying similarity between motifs. Genome Biol., 8, R24.